Insulin resistance and enhanced protein glycation in men with prehypertension

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 12, 2006, Pages 1457-1461

  Sathiyapriya, Viswanathan ^a   Nandeesha, Hanumanthappa ^a   Bobby, Zachariah ^a   Pavithran, Purushothaman ^a   Selvaraj, Nambiar ^a   Rattina Dasse, Nadaradjan ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Hyperinsulinemia; Hypertension; Insulin resistance; Prehypertension; Protein glycation

Indexed keywords

FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN; INSULIN; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; EVALUATION; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; CHOLESTEROL, HDL; CHOLESTEROL, VLDL; FRUCTOSAMINE; GLYCOSYLATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; SYNDROME; TRIGLYCERIDES;

EID: 33845689950     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.264     Document Type: Article

References (37)

1. Reddy KS. Hypertension control in developing countries: generic issues. J Hum Hypertens 1996;10:S33-8.
2. Gupta R. Meta analysis of prevalence of hypertension in India. Indian Heart J 1997;49:43-8.
3. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
4. Salonen JT, Lakka JA, Lakka HM, Valkonen VP, Everson SA, Kaplan GA. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle aged men. Diabetes 1998;47:270-5.
5. Stolar MW. Atherosclerosis in diabetes: the role of hyperinsulinemia. Metabolism 1988;37:1-9.
6. Reaven GM. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med 2005;47:201-10.
7. Sheu WH, Jeng CY, Shieh SM, Fuh MM, Shen DD, Chen YD, et al. Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. Am J Hypertens 1992;5:444-8.
8. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 1991;10:339-52.
9. Zhoa R, Shen GX. Functional modulation of antioxidant enzymes in vascular endothelial cells by glycated LDL. Atherosclerosis 2005;179:277-84.
10. Chowdhury TA, Lasker SS. Elevated glycated haemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarction. Postgrad Med J 1998;74:480-1.
11. Sabater J, Quereda C, Herrera I, Pascual J, Villafruella JJ, Ortuno J. Nonenzymatic glycosylation of hemoglobin and total plasmatic proteins in end-stage renal disease. Am J Nephrol 1991;11:37-43.
12. Nilsson PM, Lind L, Pollare T, Berne C, Lithell HO. Increased level of hemoglobin A1C, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers. Metabolism 1995;44:557-61.
13. Roberts RN, Traub AI, Kennedy AL, Hadden DR. Glycosylated haemoglobin and hypertension arising in pregnancy. Br J Obest Gynaecol 1998;105:1122-4.
14. Kanauchi M, Kanauchi K, Hashimoto T, Saito Y. Metabolic syndrome and new category "pre-hypertension" in a Japanese population. Curr Med Res Opin 2004;20:1365-70.
15. Cordero A, Laclaustra M, León M, Grima A, Casasnovas JA, Luengo E, et al. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy. Am J Hypertens 2006;19:189-96.
16. Chobanian AV, Bakris GR, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc 2003;289:2560-72.
17. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart study: a cohort study. Lancet 2001;358:1682-6.
18. Das SK, Sanyal K, Basu A. Study of urban community survey in India: growing trend of high prevalence of hypertension in a developing country. Int J Med Sci 2005;2:70-8.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-9.
21. Grunfeld BM, Balzareti M, Romo M, Gimenez M, Gutman R. Hyperinsulinemia in normotensive offspring of hypertensive patients. Hypertension 1994;3:112-5.
22. Cubeddu LX, Hoffmann IS. Insulin resistance and uppernormal glucose levels in hypertension: a review. J Hum Hypertens 2002;16:S52-5.
23. Capaldo B, Lembo G, Napoli R, Rendina V, Albano G, Sacca L, et al. Skeletal muscle is primary site of insulin resistance in essential hypertension. Metabolism 1991;40:1320-2.
24. Ferrannini E. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-7.
25. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003;139:802-9.
26. McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol 2005;96:399-404.
27. Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, et al. Total cholesterol/HDL cholesterol ratio vs. LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med 2001;61:2685-92.
28. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 1992;41:715-22.
29. Garg A. Insulin resistance in the pathogenesis of dyslipidemia. Diabetes Care 1996;19:387-9.
30. Laakso M. The possible pathophysiology of insulin resistance syndrome. Cardiovasc Risk Factors 1993;3:55-66.
31. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular events. Am J Med 2006;119:133-41.
32. Sowers JR, Standley PR, Ram JL, Jacober S, Simpson L, Rose K. Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens 1993;6:S260-70.
33. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide accounts for insulin's vascular effects in humans. J Clin Invest 1994;94:2511-5.
34. Suzuki M, Shinozaki K, Kanazawa A, Hara Y, Hattori Y, Tsushima M, et al. Insulin resistance as an independent risk factor for carotid wall thickening. Hypertension 1996;28:593-8.
35. Lapolla A, Tessari P, Poli T, Valerio A, Duner E, Iori E, et al. Reduced in vivo activity of in vitro glycosylated insulin. Diabetes 1988;37:787-91.
36. Jain SK, Palmer M. The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins. Free Radic Biol Med 1997;22:593-6.
37. Selvaraj N, Bobby Z, Sathiyapriya V. Effect of lipid peroxides and antioxidants on glycation of hemoglobin: an in vitro study on human erythrocytes. Clin Chim Acta 2006;366:190-5.